SARS-CoV-2 Spike protein trimer showing Furin Cleavage Site and conformational states

Failed Resolution: Why mRNA Experiments Must Halt

Manufacturing switch, DNA contamination, spike persistence, IgG4 immune tolerance, amyloid microclots, and regulatory failure converge on one conclusion: mRNA experiments must halt until safety is demonstrated.

Post-Pandemic Opportunistic Infections: Beyond Candida

A comprehensive clinical analysis of how COVID-19 disrupts immune function and microbiome balance, increasing susceptibility to secondary infections beyond common fungal pathogens, with special attention to emerging post-intervention syndromes.

Proteomic analysis of pathological clot composition

Beyond Blood Clots: mRNA Technology, PAD4, and 'Calamari' Thrombosis

Molecular analysis of unusual 'calamari clots' reveals connections between lipid nanoparticles, PAD4 citrullination, and treatment-resistant thrombosis. Limited human evidence; proteomic data from investigator reports requires validation.

Fluorescence micrograph showing Thioflavin T-positive amyloid fibrils with green staining against dark background, demonstrating beta-sheet structures in blood sample

Amyloid Fibrin Microclots: Long COVID Treatment & Mass Casualty Crisis | Kevin McCairn PhD

Kevin McCairn PhD's research on amyloid fibrin microclots causing Long COVID and post-vaccination syndromes. Evidence for nattokinase treatment and the crisis of misdiagnosis.

Visual representation of spike protein persistence mechanisms showing microclots, viral reactivation, and cellular dysfunction

Spike Persistence: Microclots, Reactivated Viruses, and Failed Clearance

Recent studies, including 2024-2025 work, indicate SARS-CoV-2 and its spike protein can persist for months, with links to immune changes, latent herpesvirus reactivation, and fibrin(ogen) amyloid microclots. These mechanisms may help explain features of Long COVID and some post-vaccination syndromes.

Amyloid Pathology: SDF-1, Spike–Fibrin Interactions & Microclots

Curated archive of X posts, media, and papers on SDF-1, stem cells, spike–amyloid interactions, fibrin microclots, and related literature.